Shopping Cart
- Remove All
Your shopping cart is currently empty
Tanimilast (CHF-6001) is a novel, potent, and selective phosphodiesterase 4 inhibitor with an IC50 value of 0.026 ± 0.006 nM. It exhibits potent anti-inflammatory activity and is indicated for topical use in the lungs. Tanimilast was studied for its effects on obstructive lung disease.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $233 | In Stock | |
| 5 mg | $579 | In Stock | |
| 10 mg | $868 | In Stock | |
| 25 mg | $1,460 | In Stock | |
| 50 mg | $1,970 | In Stock | |
| 100 mg | $2,650 | In Stock |
| Description | Tanimilast (CHF-6001) is a novel, potent, and selective phosphodiesterase 4 inhibitor with an IC50 value of 0.026 ± 0.006 nM. It exhibits potent anti-inflammatory activity and is indicated for topical use in the lungs. Tanimilast was studied for its effects on obstructive lung disease. |
| Targets&IC50 | PDE4:0.026±0.006 nM |
| In vitro | Methacholine-induced protein expression of smooth muscle-myosin was fully inhibited by CHF-6001 (0.3-100 nM; Guinea pig precision-cut lung slices). CHF-6001 did not affect airway closure and had limited effects on TGF-β1-induced remodeling, but rather, it inhibited methacholine-induced TGF-β release.[2] |
| Synonyms | CHF-6001 |
| Molecular Weight | 687.54 |
| Formula | C30H30Cl2F2N2O8S |
| Cas No. | 1239278-59-1 |
| Smiles | [C@@H](CC=1C(Cl)=CN(=O)=CC1Cl)(OC(=O)C2=CC(OCC3CC3)=C(NS(C)(=O)=O)C=C2)C4=CC(OCC5CC5)=C(OC(F)F)C=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (72.72 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.